Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents
- PMID: 3016581
- DOI: 10.1007/BF00965212
Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents
Abstract
The two 3H-labeled agonists [3H]8-hydroxy-2-(di-n-propylamino) tetralin ([3H]8-OH-DPAT) and [3H]serotonin ([3H]5-HT) have been used to examine the effects of physico-chemical parameters and modulatory agents on the high affinity 5-HT receptor binding sites in various regions of the rat central nervous system. Sites labeled by [3H]8-OH-DPAT and [3H]5-HT were differentially sensitive to changes in incubation temperature and pH, such that the optimal interaction of [3H]8-OH-DPAT with specific sites in the striatum was at 30 degrees C and pH 7.4, whereas [3H]5-HT sites in the same region were most easily labeled at 2-23 degrees C and pH 8.2. Micromolar concentrations of Mn2+ enhanced [3H]5-HT binding but inhibited markedly [3H]8-OH-DPAT binding to striatal membranes. In contrast, both [3H]5-HT and [3H]8-OH-DPAT binding were increased by the cation in hippocampal membranes. Conversely, GTP reduced the binding of either ligand in the hippocampus but affected only [3H]5-HT binding in the striatum. Furthermore, N-ethylmaleimide inhibited equally [3H]5-HT and [3H]8-OH-DPAT binding to hippocampal membranes, but was markedly less potent against [3H]8-OH-DPAT binding to striatal membranes. These results led to the definition of assay conditions for studying separately [3H]8-OH-DPAT binding to "hippocampal-like" (HL) and "striatal-like" (SL) sites. [3H]8-OH-DPAT HL binding sites were particularly abundant in the hippocampus, septum and cerebral cortex, and exhibited pharmacological properties typical of the postsynaptic 5-HT1A subsites previously characterized with [3H]5-HT as the ligand. The regional distribution of [3H]8-OH-DPAT SL binding sites was strikingly different from that of HL sites, but similar to that of serotoninergic terminals identified by their capacity to take up [3H]5-HT. The selective lesion by 5,7-dihydroxytryptamine of serotoninergic projections induced a marked loss of [3H]8-OH-DPAT SL binding sites in the striatum and the cerebral cortex, indicating that these sites were located presynaptically. In contrast, [3H]5-HT binding sites remained unchanged in lesioned rats, which confirmed further their exclusive postsynaptic location in brain.
Similar articles
-
[3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.J Neurochem. 1985 Jun;44(6):1685-96. doi: 10.1111/j.1471-4159.1985.tb07155.x. J Neurochem. 1985. PMID: 3157780
-
[3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.J Pharm Pharmacol. 1988 Dec;40(12):888-91. doi: 10.1111/j.2042-7158.1988.tb06296.x. J Pharm Pharmacol. 1988. PMID: 2907586
-
Further characterisation of [3H]8-hydroxy-2-(di-N-propylamino)tetralin binding sites in human brain postmortem.Neurochem Int. 1997 Feb;30(2):149-57. doi: 10.1016/s0197-0186(96)00050-2. Neurochem Int. 1997. PMID: 9017662 Clinical Trial.
-
[Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].Yakubutsu Seishin Kodo. 1989 Jun;9(2):197-206. Yakubutsu Seishin Kodo. 1989. PMID: 2530729 Japanese.
-
The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.J Neurochem. 1991 May;56(5):1705-16. doi: 10.1111/j.1471-4159.1991.tb02071.x. J Neurochem. 1991. PMID: 1826520
Cited by
-
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.Naunyn Schmiedebergs Arch Pharmacol. 2005 Mar;371(3):169-77. doi: 10.1007/s00210-005-1035-9. Epub 2005 Apr 27. Naunyn Schmiedebergs Arch Pharmacol. 2005. PMID: 15900510
-
Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors.J Neural Transm (Vienna). 1997;104(10):1059-75. doi: 10.1007/BF01273319. J Neural Transm (Vienna). 1997. PMID: 9503258
-
Metal ion and guanine nucleotide modulations of agonist interaction in G-protein-coupled serotonin1A receptors from bovine hippocampus.Cell Mol Neurobiol. 1998 Oct;18(5):535-53. doi: 10.1023/a:1026383527092. Cell Mol Neurobiol. 1998. PMID: 9777253 Free PMC article.
-
Central and peripheral hypotensive activity of urapidil and its M1 and M2 metabolites in the cat.Drugs. 1990;40 Suppl 4:34-7. doi: 10.2165/00003495-199000404-00009. Drugs. 1990. PMID: 1982652 No abstract available.
-
Identification of 5-hydroxytryptamine1A receptor agents using a composite pharmacophore analysis and chemical database screening.Naunyn Schmiedebergs Arch Pharmacol. 1991 Feb;343(2):109-16. doi: 10.1007/BF00168596. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 2067585
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources